Literature DB >> 3194059

Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis.

G M Franklin1, R K Heaton, L M Nelson, C M Filley, C Seibert.   

Abstract

Sixty patients with chronic/progressive MS received a newly assembled neuropsychological screening battery (NSB) and a brain MRI. A neuroradiologist blinded to NSB findings quantified cerebral lesions on MRI. We developed weighted brain area lesion scores according to number and size of cerebral lesions. Patients who were impaired on NSB testing had a significantly higher mean bihemispheric lesion score (X = 26.1) than those who were unimpaired (X = 17.4); this MRI lesion rating score correlated significantly with the cognitive summary score of the NSB (r = 0.35, p less than 0.01). However, we did not find a significant correlation between the Kurtzke Expanded Disability Status Scale and any MRI or NSB summary measures. Compared with the Mini-Mental State Exam (MMSE), the NSB cognitive summary score yielded a prevalence estimate for cognitive impairment that is more consistent with previous findings in chronic/progressive MS. The NSB is a useful screening test for cognitive dysfunction in chronic/progressive MS because of its relationship to cerebral lesions on MRI and its greater sensitivity than the frequently used MMSE.

Entities:  

Mesh:

Year:  1988        PMID: 3194059     DOI: 10.1212/wnl.38.12.1826

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Multiple sclerosis and the mind.

Authors:  M A Ron; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

2.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

3.  Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Authors:  A D Eastvold; R K Heaton; K S Cadenhead
Journal:  Schizophr Res       Date:  2007-04-30       Impact factor: 4.939

4.  Korsakoff's syndrome as the initial presentation of multiple sclerosis.

Authors:  A Vighetto; N Charles; M Salzmann; C Confavreux; G Aimard
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

5.  Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.

Authors:  Michele Malaguarnera; Marco Vacante; Massimo Motta; Maria Giordano; Giulia Malaguarnera; Rita Bella; Giuseppe Nunnari; Liborio Rampello; Giovanni Pennisi
Journal:  Metab Brain Dis       Date:  2011-08-26       Impact factor: 3.584

6.  Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging.

Authors:  G P Anzola; L Bevilacqua; S F Cappa; R Capra; L Faglia; E Farina; G Frisoni; C Mariani; M P Pasolini; L A Vignolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

Review 7.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 8.  The neuropsychology of multiple sclerosis: contributions of neuroimaging research.

Authors:  H A Wishart; L Flashman; A J Saykin
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

9.  Regional lobar atrophy predicts memory impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov; Dominic A Carone; Bianca Weinstock-Guttman; Jeff Gaines; Cosimo Maggiore; Jitendra Sharma; Maria-Antonietta Tomassi; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

10.  MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis.

Authors:  J C Fulton; R I Grossman; J Udupa; L J Mannon; M Grossman; L Wei; M Polansky; D L Kolson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.